| Primary |
| Hypercholesterolaemia |
24.7% |
| Blood Cholesterol Increased |
23.2% |
| Hyperlipidaemia |
10.9% |
| Hypertension |
10.5% |
| Blood Cholesterol |
7.5% |
| Dyslipidaemia |
4.5% |
| Diabetes Mellitus |
2.6% |
| Coronary Artery Disease |
2.1% |
| Type Iia Hyperlipidaemia |
2.1% |
| Type 2 Diabetes Mellitus |
1.5% |
| Myocardial Ischaemia |
1.4% |
| Atrial Fibrillation |
1.3% |
| Prophylaxis |
1.2% |
| Angina Pectoris |
1.1% |
| Asthma |
1.0% |
| Cardiac Disorder |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Blood Cholesterol Abnormal |
0.9% |
| Low Density Lipoprotein Increased |
0.8% |
| Blood Triglycerides Increased |
0.7% |
|
| Myalgia |
18.0% |
| Rhabdomyolysis |
12.4% |
| Pain In Extremity |
8.0% |
| Pancreatitis |
7.4% |
| Pain |
4.9% |
| Vomiting |
4.9% |
| Muscular Weakness |
4.4% |
| Hepatic Function Abnormal |
4.2% |
| Rash |
4.1% |
| Renal Failure Acute |
4.1% |
| Liver Disorder |
3.6% |
| Myocardial Infarction |
3.4% |
| Muscle Spasms |
3.4% |
| Renal Failure |
3.3% |
| Weight Decreased |
3.0% |
| Urticaria |
2.4% |
| Diarrhoea |
2.3% |
| Swollen Tongue |
2.2% |
| Drug Ineffective |
2.1% |
| Pancreatitis Acute |
2.0% |
|
| Secondary |
| Blood Cholesterol Increased |
18.4% |
| Hypertension |
10.9% |
| Product Used For Unknown Indication |
10.2% |
| Hypercholesterolaemia |
10.1% |
| Hyperlipidaemia |
9.6% |
| Drug Use For Unknown Indication |
7.5% |
| Blood Cholesterol |
4.9% |
| Cardiac Disorder |
4.5% |
| Diabetes Mellitus |
4.4% |
| Coronary Artery Disease |
4.0% |
| Prophylaxis |
2.2% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Hypothyroidism |
1.8% |
| Blood Cholesterol Abnormal |
1.6% |
| Blood Pressure Abnormal |
1.6% |
| Hormone Replacement Therapy |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Dyslipidaemia |
1.3% |
| Back Pain |
1.2% |
| Colorectal Cancer Metastatic |
1.1% |
|
| Myalgia |
16.1% |
| Rhabdomyolysis |
11.8% |
| Weight Decreased |
8.8% |
| Pain |
8.6% |
| Pain In Extremity |
7.1% |
| Vomiting |
6.5% |
| Drug Hypersensitivity |
6.0% |
| Liver Disorder |
4.5% |
| Pancreatitis Acute |
3.3% |
| Myocardial Infarction |
2.8% |
| Urinary Tract Infection |
2.8% |
| Weight Increased |
2.8% |
| Drug Ineffective |
2.5% |
| Muscular Weakness |
2.5% |
| Rash |
2.5% |
| Blood Creatine Phosphokinase Increased |
2.3% |
| Muscle Disorder |
2.3% |
| Muscle Spasms |
2.3% |
| Pelvic Pain |
2.3% |
| Pneumonia |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.5% |
| Drug Use For Unknown Indication |
15.9% |
| Hypertension |
8.6% |
| Blood Cholesterol Increased |
8.5% |
| Diabetes Mellitus |
4.6% |
| Type 2 Diabetes Mellitus |
2.8% |
| Pain |
2.7% |
| Cardiac Disorder |
2.5% |
| Rheumatoid Arthritis |
2.3% |
| Depression |
2.2% |
| Blood Cholesterol |
2.2% |
| Hyperlipidaemia |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Osteoporosis |
1.8% |
| Atrial Fibrillation |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Asthma |
1.4% |
| Smoking Cessation Therapy |
1.4% |
| Prophylaxis |
1.3% |
| Insomnia |
1.2% |
|
| Weight Decreased |
10.8% |
| Vomiting |
9.2% |
| Weight Increased |
8.4% |
| Flushing |
8.3% |
| Nausea |
6.3% |
| Myocardial Infarction |
5.8% |
| Pruritus |
5.2% |
| Drug Ineffective |
5.0% |
| Pain |
4.5% |
| Pain In Extremity |
4.3% |
| Rash |
4.2% |
| Somnolence |
3.5% |
| Vision Blurred |
3.5% |
| Dyspnoea |
3.4% |
| Urinary Tract Infection |
3.4% |
| Tremor |
3.4% |
| Myalgia |
3.0% |
| Paraesthesia |
2.7% |
| Oedema Peripheral |
2.7% |
| Urticaria |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
53.0% |
| Blood Cholesterol Increased |
7.2% |
| Angina Pectoris |
4.8% |
| Hypertension |
4.8% |
| Parkinson's Disease |
3.6% |
| Bipolar I Disorder |
2.4% |
| Blood Pressure |
2.4% |
| Diabetes Mellitus |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Hyperlipidaemia |
2.4% |
| Smoking Cessation Therapy |
2.4% |
| Thrombosis |
2.4% |
| Analgesic Therapy |
1.2% |
| Blood Cholesterol |
1.2% |
| Blood Cholesterol Abnormal |
1.2% |
| Convulsion |
1.2% |
| Diuretic Therapy |
1.2% |
| Drug Use For Unknown Indication |
1.2% |
| Fluid Retention |
1.2% |
| Glaucoma |
1.2% |
|
| Dizziness Postural |
11.8% |
| Vomiting |
11.8% |
| Agranulocytosis |
5.9% |
| Drug Interaction |
5.9% |
| Drug Level Below Therapeutic |
5.9% |
| Low Density Lipoprotein Decreased |
5.9% |
| Low Density Lipoprotein Increased |
5.9% |
| Myopathy |
5.9% |
| Nausea |
5.9% |
| Off Label Use |
5.9% |
| Pain |
5.9% |
| Pruritus |
5.9% |
| Rash |
5.9% |
| Rhabdomyolysis |
5.9% |
| Weight Decreased |
5.9% |
|
